FRAILTY STATUS VARIES BY FRIED AND ROCKWOOD FRAILTY ASSESSMENT TOOLS IN OLDER PATIENTS WITH NON ST ELEVATION ACUTE CORONARY SYNDROME MANAGED BY INVASIVE STRATEGY  by Veerasamy, Murugapathy et al.
A90
JACC March 17, 2015
Volume 65, Issue 10S
Acute Coronary Syndromes
FRailty status vaRies by FRied and Rockwood FRailty assessment tools in oldeR 
patients with non st elevation acute coRonaRy syndRome managed by invasive 
stRategy
Poster Contributions
Poster Hall B1
Saturday, March 14, 2015, 3:45 p.m.-4:30 p.m.
Session Title: Insights from Subgroups: Age, Gender and Diabetes
Abstract Category: 2. Acute Coronary Syndromes: Clinical
Presentation Number: 1138-069
Authors: Murugapathy Veerasamy, Hannah Sinclair, Weiliang Qiu, Vijayalakshmi Kunadian, Institute of Cellular Medicine, Newcastle, 
Newcastle upon Tyne, United Kingdom, Freeman Hospital, Newcastle upon Tyne, United Kingdom
background:  In developed countries increasing numbers of older patients with non ST elevation acute coronary syndrome (NSTEACS) 
are managed by invasive treatment strategy. Frailty is an independent marker of adverse cardiovascular outcomes in older patients with 
ACS. Although there are a number of frailty assessment tools available, there is no standardised assessment tool for patients with ACS. 
The aim of this study is to compare the frailty status of older patients (≥75 years) with NSTEACS managed by invasive strategy, using Fried 
(Cardiovascular Health Study) and Rockwood (Canadian Study of Health and Aging) frailty assessment tools.
methods:  191 consecutive patients (≥ 75 years) admitted to a tertiary cardiac centre for invasive management of NSTEACS were recruited 
into an ongoing study (ICON1-A Study to Improve Cardiovascular Outcomes in High Risk PatieNts with Acute Coronary Syndrome). Patients 
were grouped as frail or non-frail by Fried criteria (Frail: 0-2; non-Frail: 3-5) and Rockwood criteria (Frail: 1-4; non-frail: 5-7).
Results:  The mean age was 81.4 years (standard deviation 4.1 years) and 41.4% were females. Non ST elevation myocardial 
infarction accounted for 81.7% of patients and the rest 18.3% were patients with unstable angina. Most of the patients were managed 
by revascularisation (percutaneous coronary intervention in 85.9% and coronary artery bypass graft surgery in 3.7%) and only 10.4% of 
patients were not revascularised (medical management only) after coronary angiography. By Rockwood frailty assessment criteria 12% and 
88% respectively were frail and non-frail. In contrast prevalence of frail patients (33%) more than doubled by Fried criteria with reduction in 
non-frail (67%) patients (p <0.0001).
conclusion:  There is discordance in the prevalence of frailty status evaluated by Fried and Rockwood criteria in older patients with 
NSTEACS managed by invasive strategy. As increasing cohort of older patients with ACS are managed by invasive strategy, frailty status 
assessment for risk stratification need to be standardised in ACS patients. This will enable better comparison of outcomes following ACS in 
frail patients between studies.
